Seaport Therapeutics, Inc. (SPTX)
NASDAQ:SPTX
Want to see SPTX full AI Analyst Report?
SPTX Stock Chart & Stats
$15.78
$0.12(0.77%)
―
--
Day’s Range― - ―
52-Week Range$14.85 - $23.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)882.88K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding53,027,817
10 Day Avg. Volume501,401
30 Day Avg. Volume882,884
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPTX FAQ
What was Seaport Therapeutics, Inc.’s price range in the past 12 months?
Seaport Therapeutics, Inc. lowest stock price was $14.85 and its highest was $23.00 in the past 12 months.
What is Seaport Therapeutics, Inc.’s market cap?
Currently, no data Available
When is Seaport Therapeutics, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Seaport Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Seaport Therapeutics, Inc. overvalued?
According to Wall Street analysts Seaport Therapeutics, Inc.’s price is currently Undervalued.
Does Seaport Therapeutics, Inc. pay dividends?
Seaport Therapeutics, Inc. does not currently pay dividends.
What is Seaport Therapeutics, Inc.’s EPS estimate?
Seaport Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Seaport Therapeutics, Inc. have?
Seaport Therapeutics, Inc. has 53,027,817 shares outstanding.
What happened to Seaport Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Seaport Therapeutics, Inc.?
Currently, no hedge funds are holding shares in SPTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Seaport Therapeutics, Inc.
Seaport Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines. The company develops therapeutic candidates for conditions such as depression and anxiety disorders using its proprietary Glyph technology platform. The Glyph platform is designed to enable oral bioavailability, bypass first-pass metabolism, and reduce liver enzyme elevations or hepatotoxicity and other side effects. All therapeutic candidates in development are based on this platform, with research and development activities focused on neuropsychiatric medicines. The company serves clinicians and key opinion leaders in the healthcare and neuropsychiatric medicine sectors. The company was founded in 2024 and is based in Boston, Massachusetts.
Ownership Overview
Options Prices
Currently, No data available
---